# APTEVO THERAPEUTICS INC (APVO)

> Institutional ownership reported to the SEC as of Q2 2026, from Form 13F filings. Source: https://holderbook.com/stocks/APVO/

- Reporting holders: 9
- Reported value: $224.3K
- Shares held by institutions: 50,446 of 1,801,970 outstanding
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GSA CAPITAL PARTNERS LLP](https://holderbook.com/funds/1362033-gsa-capital-partners-llp/) | $96.0K | 21,539 | 0.0% | 2 |
| [VANGUARD CAPITAL MANAGEMENT LLC](https://holderbook.com/funds/2100119-vanguard-capital-management-llc/) | $56.4K | 12,713 | 0.0% | 2 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $48.0K | 10,821 | 0.0% | 2 |
| [VANGUARD FIDUCIARY TRUST CO](https://holderbook.com/funds/933478-vanguard-fiduciary-trust-co/) | $18.4K | 4,142 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $3.2K | 730 | 0.0% | 3 |
| [OSAIC HOLDINGS, INC.](https://holderbook.com/funds/1677044-osaic-holdings-inc/) | $1.6K | 360 | 0.0% | 3 |
| [SBI Securities Co., Ltd.](https://holderbook.com/funds/1851815-sbi-securities-co-ltd/) | $484 | 109 | 0.0% | 3 |
| [BARCLAYS PLC](https://holderbook.com/funds/312069-barclays-plc/) | $138 | 31 | 0.0% | 1 |
| [DANSKE BANK A/S](https://holderbook.com/funds/800177-danske-bank-a-s/) | $4 | 1 | 0.0% | 3 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q2 2026 | 9 | $224.3K |
| Q1 2026 | 9 | $229.7K |
| Q4 2025 | 10 | $191.4K |
| Q3 2025 | 12 | $717.1K |
| Q2 2025 | 7 | $45.9K |
| Q1 2025 | 8 | $22.8K |
| Q4 2024 | 13 | $208.7K |
| Q3 2024 | 17 | $231.2K |
| Q2 2024 | 18 | $599.1K |
| Q1 2024 | 10 | $14.4K |
| Q4 2023 | 30 | $360.4K |
| Q3 2023 | 26 | $1.1M |